Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Experimental Hematology
|
November 1, 1990
The effect of transforming growth factor-beta 1 on glycosaminoglycan production by human marrow cultures
D L Uhlman, D L Mooradian, L T Furcht, et al.
Leukemia Research
|
November 26, 1999
Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications
P Gupta, S C LeRoy, S D Luikart, et al.
Leukemia
|
January 1, 1989
Serum and urine glycosaminoglycans in myeloid leukemia and myelodysplasia
S D Luikart, L Fosdick, K M Ogle, et al.
Cancer Research
|
June 15, 1990
A heparan sulfate-containing fraction of bone marrow stroma induces maturation of HL-60 cells in vitro
S D Luikart, C A Maniglia, L T Furcht, et al.
Cancer Treatment Reports
|
May 1, 1987
High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B Study
S D Luikart, K J Propert, C R Modeas, et al.
British Journal of Haematology
|
May 1, 1992
Epidermolysis bullosa acquisita induced by GM-CSF: a role for eosinophils in treatment-related toxicity
J C Ward, J B Gitlin, D J Garry, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 1, 1996
A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer: a cancer and leukemia group B study
E P Mitchell, M C Perry, S D Luikart, et al.
American Journal of Clinical Oncology
|
April 1, 1993
Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group B
S D Luikart, M Goutsou, E D Mitchell, et al.
American Journal of Clinical Oncology
|
February 1, 1997
Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832)
S D Luikart, J E Herndon, D R Hollis, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Experimental Hematology
|
November 1, 1990
The effect of transforming growth factor-beta 1 on glycosaminoglycan production by human marrow cultures
D L Uhlman, D L Mooradian, L T Furcht, et al.
Leukemia Research
|
November 26, 1999
Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications
P Gupta, S C LeRoy, S D Luikart, et al.
Leukemia
|
January 1, 1989
Serum and urine glycosaminoglycans in myeloid leukemia and myelodysplasia
S D Luikart, L Fosdick, K M Ogle, et al.
Cancer Research
|
June 15, 1990
A heparan sulfate-containing fraction of bone marrow stroma induces maturation of HL-60 cells in vitro
S D Luikart, C A Maniglia, L T Furcht, et al.
Cancer Treatment Reports
|
May 1, 1987
High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B Study
S D Luikart, K J Propert, C R Modeas, et al.
British Journal of Haematology
|
May 1, 1992
Epidermolysis bullosa acquisita induced by GM-CSF: a role for eosinophils in treatment-related toxicity
J C Ward, J B Gitlin, D J Garry, et al.
Lung Cancer (Amsterdam, Netherlands)
|
September 1, 1996
A phase I/II trial of etoposide and cisplatin in extensive small cell lung cancer: a cancer and leukemia group B study
E P Mitchell, M C Perry, S D Luikart, et al.
American Journal of Clinical Oncology
|
April 1, 1993
Phase I/II trial of etoposide and carboplatin in extensive small-cell lung cancer. A report from the Cancer and Leukemia Group B
S D Luikart, M Goutsou, E D Mitchell, et al.
American Journal of Clinical Oncology
|
February 1, 1997
Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832)
S D Luikart, J E Herndon, D R Hollis, et al.
Page
of 3